Öhman Sverige A

Equity fund

1 year

Globe

Europe

Largest region

High

Risk

Annual costs

Morningstar

 

Partial 

Sustainability

Development

Last 5 years
( ann.)

Description

  • The fund is an equity fund with the aim of outperforming the performance of the Swedish stock market. The fund is actively and sustainably managed. The fund invests primarily in Swedish equities divided into different industries. The fund has specific and explicit criteria for investing in companies based on environmental, social and governance (ESG) aspects. Sustainability aspects are explicitly part of the investment process and affect the fund's investments. The fund promotes environmental and social characteristics in accordance with Article 8 of the Disclosure Regulation and is classified as a "light green" fund.

Investment horizon

  • Öhman Sverige A is a Equity fund. This mutual fund type is suitable for those who plan to save for at least 6 years.

Characteristics

  • Minimum amount
  • Sharpe 3 years
  • Price/NAV

    17 Sept 2025

  • Start date
    18 Aug 2013
  • ISIN
    SE0005281953

Risk

  • High (5 of 7)

Morningstar rating

  • The Morningstar Rating is an objective standard that tells us how well a fund has done compared to similar funds. If a fund performs better than other funds it is compared with, it receives a high rating. Correspondingly, a fund receives a low rating if it performs worse than similar funds.

Sustainability

Annual cost

  • Ongoing costs

    Includes management fees of 1,25 %

  • Platform fee
  • Kickback fee
  • Annual running costs

Other costs

  • Performance-based fee
  • Transaction costs
  • Costs for any currency exchanges are not included.

Allocation

  • Stocks 99%
    Interest 1%

Portfolio

Shows the fund's largest investments.

  • Hexagon AB Class B
    4.9%
  • SKF AB Class B
    4.8%
  • Volvo AB Class B
    4.5%
  • Atlas Copco AB Class B
    4.3%
  • AstraZeneca PLC
    3.9%
  • EQT AB Ordinary Shares
    3.8%
  • Investor AB Class B
    3.7%
  • Nordea Bank Abp
    3.7%
  • Indutrade AB
    3.6%
  • Swedish Orphan Biovitrum AB
    3.4%